Building the future

Seqera Labs is on a mission to simplify complex data analysis pipelines in the cloud. Seqera provides software that enables developers and data scientists to create and deploy data applications in any environment. Our core, open-source technology Nextflow transforms the building of massively scalable and distributed computing solutions. Seqera is now empowering customers across pharma, genomics and biotech to break with the status quo of closed-platforms and custom scripts to embrace the Nextflow future of cloud.

Doccla is pioneering the virtual ward technology needed to ease pressure on hospitals and other healthcare providers. Doccla is reinventing remote patient monitoring (RPM) with innovative medical monitoring solutions to deliver safe, effective care from the home. This helps hospitals alleviate the pressure on resources, enabling the early discharge of patients while remaining under the care of clinicians. Industry-leading patient compliance, together with fewer readmissions and lower costs, have direct effects on healthcare providers and patients who can be taken care of in the comfort of their homes.

Cancer complexity leads to a 96% failure rate of drug candidates in clinical trials and a shortage of new treatments. Orakl Oncology’s ambition is to finally address the heterogeneity of cancer and patient specificities as early as possible in drug development. By creating a collection of avatars of patients’ tumors, they predict how each patient will respond to future drugs. Orakl Oncology is an interdisciplinary techbio platform that combines best-in-class biology with deep clinical data and machine learning to efficiently discover and optimize new treatments for the right patients. Thanks to their technology, Orakl Oncology works with drug developers to bring better drugs to patients, faster.

Some companies specialize in stealing our time on screens, using features like notifications, infinite scrolling, A.I. curated feeds, subconscious triggers and disappearing stories. Opal helps you take control of your technology, so you can regain time that's been stolen from you. Their app identifies and blocks distractions, allows you to set screen timers, personal intentions for your time, and receive personalized nudges to help you find balance each day.

The Lowdown is a community based women's health review, advice and prescriptions platform. Starting with contraception, they are on a mission to put women in control of their reproductive health decisions through their unique dataset, digital tools and services.

‍

With only one in six patients knowing their costs upfront, and providers losing up to 10% of revenue to insurer underpayments, healthcare financial inefficiency is widespread in the US, even though clinics spend over 20% of their budgets on billing and collections. 

‍

Fuse uses AI to automate tedious tasks like checking portals and calling insurers, so patients get accurate cost estimates before treatment and clinics save time previously spent on manual estimates and bill explanations.

Flinn's vision is to make high-quality health products accessible for everyone. The first major milestone on this journey is to enable medical device manufacturers to automate quality and regulatory processes. The go-to-market product sets the focus on the automation of post-market surveillance processes. This means automating the collection, evaluation, and reporting of relevant data through smart workflows, integrations, and the support of AI.

Having offered fertility clinical advice longer than anyone else in Europe, Fertifa now also provides clinical care advice and wellbeing support for all of women’s health including menopause; men’s reproductive health; and fertility and family-forming. Fertifa is the most inclusive and comprehensive benefits provider for reproductive, hormonal and sexual health, making it accessible for any individual, regardless of gender, sexual orientation, age or relationship status.

Juli integrates previously siloed data like data from smartphones and other wearables, environmental data and EHR data into one platform. All that data is analyzed to identify patterns and give recommendations that guide users towards better health. A patient-centric app allows the user to see their data in one dashboard, keep a journal, get reminders for their medication or be nudged towards micro-behavioural changes in a gamified way. 

juli is a SMART on FHIR platform that integrates easily into all kinds of health systems. This enables care providers to predict when a patient needs additional outreach to avoid a crisis and generates a common understanding of a patient's health status.

nilo.health makes high-quality mental health support easily accessible for everyone, enabling employers to conveniently and effectively offer mental health services as a company benefit. Through its evidence-based and confidential platform, nilo.health provides employees with the right level of care based on their individual needs: the support ranges from 1 on 1 sessions with psychologists to group sessions and digital, self-guided tools.

DasLab’s vendor-neutral platform bridges the gap between medical diagnostic tests and the latest approaches to healthcare at distance, enabling seamless integration of physical and virtual processes to achieve improved health outcomes. Healthcare providers connect to the platform quickly and securely via an API that uses globally recognized data standards (FHIR & LOINC). 

Once connected, telemedicine providers, digital therapeutics, symptom checkers, and other providers can easily incorporate diagnostic testing and results into their virtual or hybrid care models. Laboratories that integrate with the platform benefit from increased test volume and access to new revenue models.

Charles is a digital clinic that addresses chronic health issues in men, such as sexual health, hair loss, or insomnia. Based in France, the startup offers all its services via an integrated digital platform developed in close collaboration with prominent medical experts on men’s health.

MiLaboratories is the leader in immunome data analysis software with flagship product MiXCR. MiXCR is a top-notch solution to analyze immunology sequencing data. Our software is used in vaccine, cancer, antibodies, and autoimmune diseases drug development pipelines. We provide a secure, scalable, and fast solution that helps thousands of researchers around the globe to discover new drugs and therapies.

roclub offers a teleoperation platform for medical technology to bridge the shortage of medical technical professionals and secure business continuity at any time, at any location and for any examination.

‍

The platform enables the remote access and operation of medical technology like MRI and CT scanners, facilitating use cases like remote scanning, remote (application)support, and remote education.

‍

Molecule is creating collaborative ecosystems, where stakeholders in drug development can work together to expedite the process of bringing novel therapeutics to patients. They are connecting leading researchers to funding by turning intellectual property and its development into a liquid and easily investable asset.

Speech therapists still assign homework on sheets of paper, because the industry has not yet been digitized. BlubBlub decided to change this by introducing its video app, which triggers sounds and words recorded by children and for children, helping them to practice in their specific language to address their specific speech problem. BlubBlub connects children, therapists and parents on one platform to ensure everyone plays a role in each child's progress.

9amHealth offers complete cardiometabolic care—a first-of-its-kind, whole-body approach to preventing and treating diabetes, obesity, high cholesterol, and hypertension. 9amHealth partners with employers, PBMs and healthplans to provide effective health benefits for those living with chronic conditions. Their members receive personalized care plans, prescription delivery, at-home lab tests, and unlimited specialist access.

‍

Rivia addresses inefficiencies in biopharma clinical trials, where fragmented data and outdated tools hinder the development of new therapies. Their technology offers a real-time, integrated view of data to improve the evaluation of new treatments and trial conduct. Their vision is to become the unified data infrastructure that transforms clinical development lifecycles, bringing new therapies to market more successfully.

IOMED is a solution that helps understand free text from EHRs, letters, etc. to provide better ICD-10 coding and big data insights for hospitals. It uses sophisticated medical NLP and is seamlessly integrated into the existing IT landscape.

Five Lives builds engaging and accessible digital tools for the tracking and improvement of cognitive health. Their mobile app helps prevent and detect dementia years earlier and at a fraction of the cost of current methods, extending quality of life for millions of people through personalized lifestyle improvements.

‍
The Five Lives team is diverse and experienced with proven ability to build and scale world-leading mobile apps. The core team worked together previously at Peak (60M downloads, 5M monthly active users), is led by successful entrepreneurs and has close input from expert scientific advisors.

Five Lives is now available on the AppStore and PlayStore in the UK and in Australia. The launch to wider European markets is planned for Q4 2022.

‍

Medicus converts health data with its cryptic numbers and medical language into a visual experience with easy-to-understand health insights and actionable recommendations. The users simply have to scan their (blood) test reports, answer some questions about their current health status and finally they will receive personalized insights and recommendations. The personal data of users is a 100% private and safely stored (only) on their devices.

Bloom Diagnostics enables anyone to measure blood markers in a few minutes directly at home or at one of their partner locations. Relevant health information is recorded in the Bloom App and evaluated in connection with the blood sample to produce a personalized health report, containing an individual analysis and actionable information. Understandable. Fast. Fully encrypted, so that nobody can access user data without their consent.

ThinkSono has created the world’s first software to diagnose ‘deep vein thrombosis’ (DVT) at the point of care. DVT is caused by a blood clot in the leg and is responsible for 800,000 deaths in Europe and the USA. ThinkSono’s solution can diagnose DVT within one step at 30 times cheaper and 10 times faster than current solutions on the market.

Elephant is a tech startup tackling big problems in global healthcare. They create lightweight, connectable applications that improve access to care and save lives. Elephant works in emerging economies and has partnered with NGOs, governments, and with healthcare professionals around the world with a view to building the future of digital health and personalized, preventative care.

Second Nature is a digital health program, proven to help people change their behaviors and reduce their risk to type 2 diabetes. It solves this issue by introducing a 6-week behavioral change program delivered digitally and supported by mentors and health tracking. Users receive a Second Nature smart scale and an activity tracker to track their health and outcomes. Additionally, they will be matched with a full-time coach, who will guide them through the prevention program and they learn how to prevent diabetes through Second Nature’s online education courses.

hi.health (acquired by Pliant in 2025) offers people with private health insurance convenient and safe access to health care billing via app or web. Users can easily submit their invoices digitally and hi.health takes care of the further processing, billing and customer service providing a seamless user experience. With the integrated “library” users receive a transparent overview of relevant digital health products and services, that are (partially) covered by their insurance.

hi.health operates at the intersection of digital health, fintech and insurtech. While each of these rapidly growing markets are already exciting by themselves, their combination in one product is unique. The company was founded by Sebastian Gruber and Fredrik Debong in July 2019.

Diagnosia (acquired by Mediately in 2022) is a mobile and web-based app, which helps doctors and other healthcare professionals make the right medication decision. Additionally, the platform serves as a highly-targeted marketing channel for pharmaceutical companies interested in advertising on the platform.

Diagnosia was founded in 2011 by a group of medical doctors, software engineers, and entrepreneurs. Over the years the company has established itself as the market leader for clinical drug information software in Austria with more than 5,000 health professionals and over 50 healthcare facilities using their app.